Surya Pharma is a stock to watch. The half yearly results are good with a 6 months EPS of Rs15. The stock is currently quoting at Rs116. If the current quarter EPS is maintained for the next two quarters, the company would end up with an yearly EPS of around Rs31. The stock is quoting a FY08 PE of less than 4.
There are many positive developments happening in the company which I will share in the days to come once I am able to collate.
On the technical side, the stock has broken out of the trading range and the first support for the stock is around 96 and below that at 90 levels.
Disclaimer: This is not an invitation to buy or sell shares. Pls take your own decision. I dont own these shares at this moment.
No comments:
Post a Comment